Norpace CR

Product NDC: 0025-2732
11-digit product format: 000252732
Labeler code: 0025
Product ID: 0025-2732_acc7751f-7484-4d53-8a6b-0194f23da1c8
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: disopyramide phosphate
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Labeler: Pfizer Laboratories Div Pfizer Inc
Application: NDA018655
Marketing category: NDA
Marketing start: 1982-07-20
Substance: DISOPYRAMIDE PHOSPHATE
Active strength: 100 mg/1
Pharmacologic classes: Antiarrhythmic [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N018655-001	NORPACE CR	DISOPYRAMIDE PHOSPHATE	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1982-07-20
N018655-002	NORPACE CR	DISOPYRAMIDE PHOSPHATE	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL		RLD, RS	1982-07-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N018655-001	NORPACE CR	EQ 100MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD	1982-07-20	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N018655-002	NORPACE CR	EQ 150MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	RLD, RS	1982-07-20	`782e0a99824c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Norpace CR
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DISOPYRAMIDE PHOSPHATE	100 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
N6BOM1935W	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 8 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
209066	Internal RxNorm lookup
209692	Internal RxNorm lookup
309958	Internal RxNorm lookup
309960	Internal RxNorm lookup
636793	Internal RxNorm lookup
636794	Internal RxNorm lookup
902648	Internal RxNorm lookup
902652	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
e2aa1642-d262-4520-bc6a-9fd3ad795677	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d08b5e1c-4339-4b83-bd26-a59d84e2a782	Product name	1	20170614

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0025-2732-31	Norpace CR	100 in 1 BOTTLE	CAPSULE, EXTENDED RELEASE	100		21

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0025-2732-31	EA - Each	0025-2732	b308d85c-b733-44ac-b6ac-e4174ebac31d	1	2012-07-24
0025-2732-51	EA - Each	0025-2732	912e8e37-ef5d-4797-a474-faa4c08fd874	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
disopyramide phosphate	ACTIVE INGREDIENT	N6BOM1935W	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
disopyramide	ACTIVE MOIETY	GFO928U8MQ	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
ethylcellulose	INACTIVE INGREDIENT	7Z8S9VYZ4B	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
FD&C RED NO. 3	INACTIVE INGREDIENT	PN2ZH5LOQY	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
gelatin	INACTIVE INGREDIENT	2G86QN327L	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
lactose	INACTIVE INGREDIENT	J2B2A4N98G	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
shellac	INACTIVE INGREDIENT	46N107B71O	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
starch, corn	INACTIVE INGREDIENT	O8232NY3SJ	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
sucrose	INACTIVE INGREDIENT	C151H8M554	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
talc	INACTIVE INGREDIENT	7SEV7J4R1U	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]	3
disopyramide phosphate	ACTIVE INGREDIENT	N6BOM1935W	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [CARILION MATERIALS MANAGEMENT]	2
disopyramide	ACTIVE MOIETY	GFO928U8MQ	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [CARILION MATERIALS MANAGEMENT]	2
ETHYLCELLULOSES	INACTIVE INGREDIENT	7Z8S9VYZ4B	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [CARILION MATERIALS MANAGEMENT]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [CARILION MATERIALS MANAGEMENT]	2
SUCROSE	INACTIVE INGREDIENT	C151H8M554	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [CARILION MATERIALS MANAGEMENT]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [CARILION MATERIALS MANAGEMENT]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [CARILION MATERIALS MANAGEMENT]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0025-2732	NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED NORPACE CR (DISOPYRAMIDE PHOSPHATE) CAPSULE, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19	Current NDC, Legacy NDC, 1 package rows	20240817_e2aa1642-d262-4520-bc6a-9fd3ad795677.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Norpace CR	DISOPYRAMIDE PHOSPHATE	Pfizer Laboratories Div Pfizer Inc	e2aa1642-d262-4520-bc6a-9fd3ad795677	2026-03-18	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 018655 application number: NDA018655 ndc (product): 0025-2732

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
N6BOM1935W	DISOPYRAMIDE PHOSPHATE	22059-60-5	DISOPYRAMIDE PHOSPHATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
636793	disopyramide phosphate 100 MG 12HR Extended Release Oral Capsule	PSN	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
309958	disopyramide phosphate 100 MG Oral Capsule	PSN	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
636794	disopyramide phosphate 150 MG 12HR Extended Release Oral Capsule	PSN	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
309960	disopyramide phosphate 150 MG Oral Capsule	PSN	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
209066	Norpace 100 MG Oral Capsule	PSN	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
209692	Norpace 150 MG Oral Capsule	PSN	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
902648	Norpace CR 100 MG 12HR Extended Release Oral Capsule	PSN	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
902652	Norpace CR 150 MG 12HR Extended Release Oral Capsule	PSN	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
902648	12 HR disopyramide 100 MG Extended Release Oral Capsule [Norpace]	SBD	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
902652	12 HR disopyramide 150 MG Extended Release Oral Capsule [Norpace]	SBD	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
209066	disopyramide 100 MG Oral Capsule [Norpace]	SBD	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
209692	disopyramide 150 MG Oral Capsule [Norpace]	SBD	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
636793	12 HR disopyramide 100 MG Extended Release Oral Capsule	SCD	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
636794	12 HR disopyramide 150 MG Extended Release Oral Capsule	SCD	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
309958	disopyramide 100 MG Oral Capsule	SCD	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
309960	disopyramide 150 MG Oral Capsule	SCD	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
902648	12 HR Norpace 100 MG Extended Release Oral Capsule	SY	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
902652	12 HR Norpace 150 MG Extended Release Oral Capsule	SY	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
309958	disopyramide 100 MG (as disopyramide phosphate) Oral Capsule	SY	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
636793	disopyramide 100 MG 12 HR Extended Release Oral Capsule	SY	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
309960	disopyramide 150 MG (as disopyramide phosphate) Oral Capsule	SY	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
636794	disopyramide 150 MG 12 HR Extended Release Oral Capsule	SY	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
209066	Norpace (as disopyramide phosphate) 100 MG Oral Capsule	SY	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
209692	Norpace (as disopyramide phosphate) 150 MG Oral Capsule	SY	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
209066	Norpace 100 MG Oral Capsule	SY	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
209692	Norpace 150 MG Oral Capsule	SY	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
902648	Norpace CR (as disopyramide phosphate) 100 MG 12 HR Extended Release Oral Capsule	SY	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
902652	Norpace CR (as disopyramide phosphate) 150 MG 12 HR Extended Release Oral Capsule	SY	e2aa1642-d262-4520-bc6a-9fd3ad795677	21
309958	disopyramide phosphate 100 MG Oral Capsule	PSN	4c02f1b8-4493-429c-b9f7-21f364e330f8	2
209066	Norpace 100 MG Oral Capsule	PSN	4c02f1b8-4493-429c-b9f7-21f364e330f8	2
209066	disopyramide 100 MG Oral Capsule [Norpace]	SBD	4c02f1b8-4493-429c-b9f7-21f364e330f8	2
309958	disopyramide 100 MG Oral Capsule	SCD	4c02f1b8-4493-429c-b9f7-21f364e330f8	2
309958	disopyramide 100 MG (as disopyramide phosphate) Oral Capsule	SY	4c02f1b8-4493-429c-b9f7-21f364e330f8	2
209066	Norpace (as disopyramide phosphate) 100 MG Oral Capsule	SY	4c02f1b8-4493-429c-b9f7-21f364e330f8	2
209066	Norpace 100 MG Oral Capsule	SY	4c02f1b8-4493-429c-b9f7-21f364e330f8	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0025-2732-31	00025273231	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0025-2732-31)	1982-07-20	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Norpace ® disopyramide phosphate capsules Norpace ® CR disopyramide phosphate extended-release capsules	Pfizer Laboratories Div Pfizer Inc \| Pfizer Manufacturing Deutschland GmbH	2026-03-18	HUMAN PRESCRIPTION DRUG LABEL	21
Norpace disopyramide phosphate capsules Norpace CR disopyramide phosphate extended-release capsules ® ®	Carilion Materials Management	2010-02-24	HUMAN PRESCRIPTION DRUG LABEL	2